His expertise as a physician helps identify critical needs for patients with advanced cancer and forms the basis for the translational research efforts in his laboratory. Dr. Raj's research group is focused on understanding the mechanisms of, and developing drugs to overcome, therapeutic resistance in prostate and breast cancers.